[b]I hate to advocate drugs, alcohol, violence, or insanity to anyone, but they've always worked for me.[/b]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
tit for tat
butter for fish....
Like there's a REAL big difference Todd DiLaMuca.
Go to Yahoo. Check out stats.
TIA
Correction 918 million shares outstanding. 80 million short of 1 billion.
Most companies don't have multi billion $dollar$ potential.
905 million OS currently.
It is amazing how companies that have absolutely no revenues and only their PIP get valued at such a high price. It has already been
brought to light that if Elite were strictly an R&D company with no
products generating revenues with which to sustain itself that Elite might be valued differently...... as in much higher a price per share. As I recall both Jerry and Nasrat had brought this up at times.
The market is what it is.... fickle.
SequestOx once approved is highly likely to be a dominant formulation given the circumstances of the current prescription
opioid abuse situation country wide.
Unless there is a way to safeguard current prescription opioids such that only the patient can take them it does not matter who prescribes them or fills the prescription. The abuse will continue
and only get worse. Pharmaceutical companies that manufacture these
drugs know this.... furthermore they don't care about the collateral damage. Only thing these companies care about is money
made from the sale of these drugs.
As for the magical way in which only the patient can have access to pills without some technological highly expensive safeguard....
there is none. Probable that there never ever will be any such solution.
Best solution to date is the technology Elite has. Once pill poppers figure out that they can't get that rush off of SequestOx
they will have to find some other means..... maybe go back to
non pharmaceutical grade heroin.
All over TV tonight about the huge problem with corrupt/reckless doctors and pharmacists
What's to say there will not be two filed in one Q?
One ANDA per quarter. What blew up in whose face?
Who manufactures the pharma grade heroin? Pharmacists? Doctors?
Not hardly. Pharmaceutical companies.
Unless there is a plan to put a chip in each pill so that it can be tracked to the person it was intended for your argument holds no
water.
Once the doc writes the prescription and the pharmacist fills it, it is the responsibility of the person taking that prescription to see that those drugs do not fall into unintended hands.
Once SequestOx is out there it really won't matter what happens.
The opioids can fall into unintended hands and the abusers can have at it. Good luck to them. LOL
Support your local pharmaceutical grade opioid manufacturer. Without them there can be no prescription opioid abuse.
Synthetic heroin.... pharmaceutical grade.
Sick......
Heroin has a tie to prescription opioid abuse, but heroin abuse is not the goal with SequestOx. Many heroin abusers prefer prescription oxycodone to heroin. For one thing it is pharmaceutical grade stuff.... something heroin is not.
The other point I wanted to make is that the article you posted has to do more with a bill that could be passed to force those addicted to heroin to be put in treatment.
And who would pay for this treatment?
The article says nothing about prescription opioid abusers and their treatment for addiction.
Once SequestOx comes onto the market then "they" can worry and concentrate on heroin addiction. The best known ADF will available
to healthcare professionals. SequestOx will be putting other pharmaceutical opioid manufacturers on notice.
Last time I was there the building had only been partially expanded.
Looks as if they now have the whole facility going.
Don't forget "Elite's ADF doesn't work" "it can be abused, street junkies will find a way" "Elite won't be able to do this" "Elite won't be able to do that""ZomBie SequestOx"...... So far Elite is doing fine.
NH and company are doing more than just opioid ADFs. They are building a very competitive pharmaceutical company. More than just a one trick pony like some pharmaceuticals out there.
just went up a tic.... now down a tic... now up a tic...
WOW, i just looked away for a bit and Elite LOST 15 again!!
People take solace in the fact that Elite has no control over share price at the moment. The market is fickle. Stocks go up and stocks go down. The key here is timing. When to buy...... when to hold....
and when to take profit.
Buy hold and accumulate.... my advice.
Sell when the insiders sell. So far no insiders have sold.
Word.....
Purdue is a one trick pony whose trick is about up. OxyContin will be facing more than just other pharmaceuticals manufacturing the turtle shell..... Purdue will be facing Elite's line of ADFs.
ADFs Purdue cannot compete with.
Opioid abuse problem came up again today during a discussion
of the AHA on The View. Prescription opioid abuse will not be covered.
As the abuse problem gets worse the fallout will rise. Elite has
the solution.
Short story, Purdue determined that their Hot Melt Extruder technology was better than $ELTP's Fluid Bed Spray Drier technology. and rejected the $ELTP offer.
but dont forget Purdue said thanks but no thanks
There are going to be ups and downs no doubt about that, however, if Elite does fall to new 52 week lows I will be a buyer accumulating even more.
Yup nothing less than a massive Global contract.
Another great post.
In addition only $ELTP has the technical R&D to develop for PuraCap a similar separate R&D development and manufacturing contract as for SunGen's 4 blockbuster ANDAs.
PuraCap paid $550 mil for Epic mediocre 15 breadcrumbs ANDAs!
Purdue beginning to flail. Beginning to realize revenues may potentially leave for good. Let the lawsuits begin.
Proactive desperation?
$2.5 million is huge money for any company John. So why did Epic (now PuraCap) decide SequestOx was worth the money in milestone payments?
Because in the short run $2.5 million ($10 million total) is a drop in the bucket of revenue to come.
So let's say that Elite and PuraCap form a mutual partnership.
A symbiotic partnership that will benefit both companies.
PuraCap brings other markets into the picture for Elite.
Lots of speculation, but could potentially be huge for both companies if they do form an agreement to work together, or if they haven't already formed that agreement.
Then there is Elite's ADF pipeline..... even more potential.
Wonder what revenues may be when Elite has Percocet, Norco, OxyContin, and SequestOx..... my guess well over $100 million/year and climbing.
A PE ratio of a conservative 15 would get Elite to what share price?
1.65?
And that is just the start. My revenue estimate is way off to the low side. OxyContin could be huge in and of itself.
Another $7.5 million when SequestOx is approved.
FYI
"In house" water distilled deionized. Means it came from the facility.
In house testing means done in house as part of R&D or other.
Actually just the opposite. It started out during the 2014 SHM as 5
then increased to 7 and went up from there.
Now if the FDA ever changes its mind about Norco or Percocet Elite has the answer for them as well. What other pharmaceutical does?
None.
Once Elite's ANDA is announced there is likely to be a tepid
reaction to the stock price, however, once SequestOx approval the market will begin to put it all together. The market will see the enormous potential..... that this next ANDA submitted by Elite will indeed be another blockbuster.
Those of us who bought low will be rewarded.
Buy hold accumulate.
Yeah Bob Radie looks to be a real winner to me. Egalet vs Elite
not a chance for Egalet. $12.5 billion dollar market and Eaglet could only tap $20 million? Elite is likely to make more on Percocet alone.
Plus the lawsuits against Egalet? I'll take NH and his team any day of the week over that "experienced team" at Eaglet.
Three years after their "professional " work they might be upset they are a bit off. A several thousand percent it seems.
If incompetence and a waste of time is a slice of about a billion dollar pie between three of four pharmaceuticals then I call that a good use of incompetence.
Wish all my investments were as incompetent. LOL LOL
Chipotle, Netflix, what was Google...... and the list goes on.
Yes it is amazing.
Thanks for that insightful information. LOL
Glad we agree on something.
For those who followed this strategy to dump out on the way to $0.96
there are also short term taxes to deal with. Some who followed this recipe may have forgotten to keep some profit on hand to pay those taxes.
This also puts those who followed this strategy in a higher tax bracket. Not too smart IMO.
And $0.96/share was just a tease at future possibilities of what will be.
800,000 at $1.60 will look even more serious. LOL LOL